Search details
1.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.
Liver Int
; 40(8): 2008-2020, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32279446
2.
Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer.
Gastric Cancer
; 21(1): 106-113, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-28667466
3.
Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study.
Jpn J Clin Oncol
; 46(12): 1088-1094, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27608646
4.
The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy.
BMC Cancer
; 12: 461, 2012 Oct 09.
Article
in English
| MEDLINE | ID: mdl-23046527
5.
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
Liver Cancer
; 10(5): 451-460, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34721507
6.
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.
JHEP Rep
; 3(2): 100215, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33392490
7.
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.
J Gastroenterol
; 55(6): 627-639, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32107609
8.
Germline PTCH1 mutations in Japanese basal cell nevus syndrome patients.
J Hum Genet
; 54(7): 403-8, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19557015
9.
Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
JAMA Netw Open
; 2(8): e198243, 2019 08 02.
Article
in English
| MEDLINE | ID: mdl-31373648
10.
Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug.
World J Surg Oncol
; 6: 17, 2008 Feb 08.
Article
in English
| MEDLINE | ID: mdl-18257933
11.
Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.
World J Gastroenterol
; 13(16): 2283-8, 2007 Apr 28.
Article
in English
| MEDLINE | ID: mdl-17511025
12.
[A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases].
Gan To Kagaku Ryoho
; 34(4): 631-4, 2007 Apr.
Article
in Japanese
| MEDLINE | ID: mdl-17431355
13.
Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer.
World J Gastroenterol
; 12(47): 7585-90, 2006 Dec 21.
Article
in English
| MEDLINE | ID: mdl-17171785
14.
ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.
World J Gastroenterol
; 12(36): 5884-9, 2006 Sep 28.
Article
in English
| MEDLINE | ID: mdl-17007058
15.
Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
Oncol Rep
; 14(5): 1177-82, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16211282
16.
Venous thromboembolism in colorectal cancer patients with central venous catheters for 5-FU infusion-based pharmacokinetic modulating chemotherapy.
Oncol Rep
; 13(4): 627-32, 2005 Apr.
Article
in English
| MEDLINE | ID: mdl-15756434
17.
Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Int J Oncol
; 21(6): 1223-8, 2002 Dec.
Article
in English
| MEDLINE | ID: mdl-12429971
18.
Gene expression in response to anti-tumour intervention by polysaccharide-K (PSK) in colorectal carcinoma cells.
Oncol Rep
; 12(6): 1287-93, 2004 Dec.
Article
in English
| MEDLINE | ID: mdl-15547752
19.
Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma.
Mol Clin Oncol
; 1(4): 773-779, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-24649245
20.
Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
Oncol Rep
; 28(2): 446-52, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22664791